Nuclear Medicine Radiopharmaceuticals-Global Market Status and Trend Report 2013-2023
SKU ID :MI-10851411 | Published Date: 02-Jan-2018 | No. of pages: 148Description
TOC
Table of Contents
Chapter 1 Overview of Nuclear Medicine Radiopharmaceuticals
1.1 Definition of Nuclear Medicine Radiopharmaceuticals in This Report
1.2 Commercial Types of Nuclear Medicine Radiopharmaceuticals
1.2.1 Diagnostic
1.2.2 Brachytherapy
1.2.3 Other Therapeutic
1.3 Downstream Application of Nuclear Medicine Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Thyroid
1.3.3 Cardiology
1.3.4 Others
1.4 Development History of Nuclear Medicine Radiopharmaceuticals
1.5 Market Status and Trend of Nuclear Medicine Radiopharmaceuticals 2013-2023
1.5.1 Global Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
1.5.2 Regional Nuclear Medicine Radiopharmaceuticals Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Nuclear Medicine Radiopharmaceuticals 2013-2017
2.2 Production Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions
2.2.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Regions
2.3 Demand Market of Nuclear Medicine Radiopharmaceuticals by Regions
2.4 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions
2.4.1 Production and Demand Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
2.4.2 Import and Export Status of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Types
3.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Types
3.3 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
4.2 Market Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Nuclear Medicine Radiopharmaceuticals
5.1 Global Economy Situation and Trend Overview
5.2 Nuclear Medicine Radiopharmaceuticals Downstream Industry Situation and Trend Overview
Chapter 6 Nuclear Medicine Radiopharmaceuticals Market Competition Status by Major Manufacturers
6.1 Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.2 Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3 Basic Information of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.3.2 Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Nuclear Medicine Radiopharmaceuticals Major Manufacturers Introduction and Market Data
7.1 Mallinckrodt
7.1.1 Company profile
7.1.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.1.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt
7.2 Isorad
7.2.1 Company profile
7.2.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.2.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad
7.3 Cardinal Health
7.3.1 Company profile
7.3.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.3.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health
7.4 Jubilant
7.4.1 Company profile
7.4.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.4.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant
7.5 Medi-Radiopharma
7.5.1 Company profile
7.5.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.5.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma
7.6 Comecer
7.6.1 Company profile
7.6.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.6.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer
7.7 Jaco
7.7.1 Company profile
7.7.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.7.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco
7.8 Ciaeriar
7.8.1 Company profile
7.8.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.8.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar
7.9 Advanced Molecular-imaging Solution
7.9.1 Company profile
7.9.2 Representative Nuclear Medicine Radiopharmaceuticals Product
7.9.3 Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution
Chapter 8 Upstream and Downstream Market Analysis of Nuclear Medicine Radiopharmaceuticals
8.1 Industry Chain of Nuclear Medicine Radiopharmaceuticals
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Nuclear Medicine Radiopharmaceuticals
9.1 Cost Structure Analysis of Nuclear Medicine Radiopharmaceuticals
9.2 Raw Materials Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.3 Labor Cost Analysis of Nuclear Medicine Radiopharmaceuticals
9.4 Manufacturing Expenses Analysis of Nuclear Medicine Radiopharmaceuticals
Chapter 10 Marketing Status Analysis of Nuclear Medicine Radiopharmaceuticals
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Diagnostic
Table Advantage and Disadvantage of Brachytherapy
Table Advantage and Disadvantage of Other Therapeutic
Table Production Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Table Production Value of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Table Production and Demand Status of Nuclear Medicine Radiopharmaceuticals in Region One 2013-2017
Table Production and Demand Status of Nuclear Medicine Radiopharmaceuticals in Region Two 2013-2017
Table Production and Demand Status of Nuclear Medicine Radiopharmaceuticals in Region Three 2013-2017
Table Production and Demand Status of Nuclear Medicine Radiopharmaceuticals in Region Four 2013-2017
Table Import Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Table Export Volume of Nuclear Medicine Radiopharmaceuticals by Regions 2013-2017
Table Production Volume of Nuclear Medicine Radiopharmaceuticals by Types 2013-2017
Table Production Value of Nuclear Medicine Radiopharmaceuticals by Types 2013-2017
Table Production Volume Forecast of Nuclear Medicine Radiopharmaceuticals by Types 2018-2023
Table Production Value Forecast of Nuclear Medicine Radiopharmaceuticals by Types 2018-2023
Table Demand Volume of Nuclear Medicine Radiopharmaceuticals by Downstream Industry 2013-2017
Table Demand Volume Forecast of Nuclear Medicine Radiopharmaceuticals by Downstream Industry 2018-2023
Table Production Volume of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 2013-2017
Table Production Value of Nuclear Medicine Radiopharmaceuticals by Major Manufacturers 2013-2017
Table Headquarters Location and Established Time of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
Table Employees and Revenue Level of Nuclear Medicine Radiopharmaceuticals Major Manufacturer
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Mallinckrodt
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Mallinckrodt
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Mallinckrodt 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Isorad
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Isorad
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Isorad 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Cardinal Health
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Cardinal Health
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Cardinal Health 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jubilant
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jubilant
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jubilant 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Medi-Radiopharma
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Medi-Radiopharma
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Medi-Radiopharma 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Comecer
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Comecer
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Comecer 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Jaco
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Jaco
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Jaco 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Ciaeriar
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Ciaeriar
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Ciaeriar 2013-2017
Table Representative Nuclear Medicine Radiopharmaceuticals Product One of Advanced Molecular-imaging Solution
Table Representative Nuclear Medicine Radiopharmaceuticals Product Two of Advanced Molecular-imaging Solution
Table Nuclear Medicine Radiopharmaceuticals Sales, Revenue, Price and Gross Margin of Advanced Molecular-imaging Solution 2013-2017
Companies
- PRICE
-
$2980$4480